CAAPX | VMVAX | CAAPX / VMVAX | |
Total Expense Ratio | 1.14 | 0.07 | 1,629% |
Annual Report Gross Expense Ratio | 1.14 | 0.07 | 1,629% |
Fund Existence | 36 years | 14 years | - |
Gain YTD | 6.888 | 7.952 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 893M | 32.5B | 3% |
Annual Yield % from dividends | 0.38 | 2.17 | 18% |
Returns for 1 year | 1.49 | 4.87 | 31% |
Returns for 3 years | 14.24 | 42.44 | 34% |
Returns for 5 years | 4.93 | 64.89 | 8% |
Returns for 10 years | -12.44 | 102.58 | -12% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFAK | 132.05 | N/A | N/A |
Stone Ridge 2052 Longevity Income ETF | |||
OVB | 20.58 | -0.03 | -0.15% |
Overlay Shares Core Bond ETF | |||
FIDI | 24.52 | -0.12 | -0.48% |
Fidelity International High Div ETF | |||
EMXC | 68.93 | -0.53 | -0.76% |
iShares MSCI Emerging Mkts ex China ETF | |||
EQAL | 52.25 | -0.44 | -0.84% |
Invesco Russell 1000 Equal Weight ETF |